Patents by Inventor Peihua JIANG

Peihua JIANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF PHARMACEUTICALS AND INGESTIBLE MATERIALS
    Publication number: 20220331431
    Abstract: Provided herein are compositions and methods of ameliorating the pharmaceutical aversiveness of active pharmaceutical ingredient (API) by administering the API after or substantially simultaneously with a flavone compound.
    Type: Application
    Filed: September 9, 2020
    Publication date: October 20, 2022
    Inventors: Erik M. Schwiebert, John H. Streiff, Peihua Jiang, Paul A.S. Breslin
  • Method of Regulating Immunity in the Intestines
    Publication number: 20220313637
    Abstract: Methods for stimulating the G protein receptor (Gpr91) pathway in intestinal cells to release IL-25 and enhance a type II immune response in the subject are useful in the treatment or prevention of bacterial or parasitic infection. Similarly methods and compositions used therein to inhibit or stimulate GPR91 are useful for the treatment or inhibition of certain diseases, such as IBS, IBD and Crohn's disease.
    Type: Application
    Filed: March 17, 2022
    Publication date: October 6, 2022
    Inventors: Peihua JIANG, Weiwei LEI
  • Method of regulating immunity in the intestines
    Patent number: 11278507
    Abstract: Methods for stimulating the G protein receptor (Gpr91) pathway in intestinal cells to release IL-25 and enhance a type II immune response in the subject are useful in the treatment or prevention of bacterial or parasitic infection. Similarly methods and compositions used therein to inhibit or stimulate GPR91 are useful for the treatment or inhibition of certain diseases, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and Crohn's disease.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: March 22, 2022
    Assignee: Monell Chemical Senses Center
    Inventors: Peihua Jiang, Weiwei Lei
  • Method of Regulating Immunity in the Intestines
    Publication number: 20210283079
    Abstract: Methods for stimulating the G protein receptor (Gpr91) pathway in intestinal cells to release IL-25 and enhance a type II immune response in the subject are useful in the treatment or prevention of bacterial or parasitic infection. Similarly methods and compositions used therein to inhibit or stimulate GPR91 are useful for the treatment or inhibition of certain diseases, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and Crohn's disease.
    Type: Application
    Filed: August 21, 2017
    Publication date: September 16, 2021
    Inventors: Peihua JIANG, Weiwei LEI